Reprogramming of cardiac phosphoproteome, proteome, and transcriptome confers resilience to chronic adenylyl cyclase-driven stress

• DOI: 10.7554/elife.88732
• Publication Date: 2023-07-26T14:28:09Z
• Authors: Jia-Hua Qu; Khalid Chakir; Kirill V Tarasov; Daniel R Riordon; Maria Grazia Perino; Allwin Jennifa Si...; Edward G Lakatta
• Keywords: Adult; 0301 basic medicine; Proteome; left ventricle; QH301-705.5; proteome; Science; 3-Phosphoinositide-Dependent Protein Kinases; Phosphatidylinositol 3-Kinases; 03 medical and health sciences; AC-cAMP-PKA-Ca2+ signaling; adenylyl cyclase 8; Humans; Biology (General); 0303 health sciences; Q; phosphoproteome; R; Cell Biology; Resilience, Psychological; Phosphoproteins; 3. Good health; Medicine; Transcriptome; transcriptome; Adenylyl Cyclases

Our prior study (Tarasov et al., 2022) discovered that numerous adaptive mechanisms emerge in response to cardiac-specific overexpression of adenylyl cyclase type 8 (TGAC8) which included overexpression of a large number of proteins. Here, we conducted an unbiased phosphoproteomics analysis in order to determine the role of altered protein phosphorylation in the adaptive heart performance and protection profile of adult TGAC8 left ventricle (LV) at 3–4 months of age, and integrated the phosphoproteome with transcriptome and proteome. Based on differentially regulated phosphoproteins by genotype, numerous stress-response pathways within reprogrammed TGAC8 LV, including PKA, PI3K, and AMPK signaling pathways, predicted upstream regulators (e.g. PDPK1, PAK1, and PTK2B), and downstream functions (e.g. cell viability, protein quality control), and metabolism were enriched. In addition to PKA, numerous other kinases and phosphatases were hyper-phosphorylated in TGAC8 vs. WT. Hyper-phosphorylated transcriptional factors in TGAC8 were associated with increased mRNA transcription, immune responses, and metabolic pathways. Combination of the phosphoproteome with its proteome and with the previously published TGAC8 transcriptome enabled the elucidation of cardiac performance and adaptive protection profiles coordinately regulated at post-translational modification (PTM) (phosphorylation), translational, and transcriptional levels. Many stress-response signaling pathways, i.e., PI3K/AKT, ERK/MAPK, and ubiquitin labeling, were consistently enriched and activated in the TGAC8 LV at transcriptional, translational, and PTM levels. Thus, reprogramming of the cardiac phosphoproteome, proteome, and transcriptome confers resilience to chronic adenylyl cyclase-driven stress. We identified numerous pathways/function predictions via gene sets, phosphopeptides, and phosphoproteins, which may point to potential novel therapeutic targets to enhance heart adaptivity, maintaining heart performance while avoiding cardiac dysfunction.